The Cost of Uncontested Denials: Revenue Walking Out the Door

The healthcare industry has a revenue leak that hides in plain sight: denied claims that are never appealed. According to data from MGMA and other industry sources, the majority of denied claims are never contested — they are written off as uncollectable without any attempt to recover the revenue. For individual practices, this represents tens or hundreds of thousands of dollars walking out the door every year. Across the healthcare system, the figure is measured in billions.

The Scale of the Problem

Multiple industry studies have converged on a striking data point: somewhere between 50% and 65% of denied claims are never appealed. The exact percentage varies by source and methodology, but the directional finding is consistent — the majority of denials go uncontested.

At the same time, data on appeal success rates shows that when practices do appeal, they win a significant portion of the time. Published appeal overturn rates range from 40% to over 70%, depending on the type of denial, the quality of the appeal, and the payer involved. The combination of these two facts — most denials are never appealed, and most appeals succeed — reveals the magnitude of the revenue left on the table.

Quantifying the Loss

Consider a specialty practice with $5 million in annual charges and a 10% initial denial rate. That practice generates $500,000 in denied claims per year. If 60% of those denials go uncontested, that is $300,000 in claims that are never appealed.

Applying a conservative 50% appeal success rate and an average 70% collection rate on overturned claims, the recoverable revenue from those uncontested denials would be approximately $105,000 per year. That is revenue the practice earned by providing care but never collected because no one submitted an appeal.

For larger practices or those with higher denial rates — which are common in specialties like oncology, rheumatology, and orthopedics — the numbers scale proportionally. A practice with $20 million in charges and a 12% denial rate could be leaving more than $500,000 in recoverable revenue uncontested annually.

Why Practices Don't Appeal

If the math so clearly favors appealing, why do most practices leave most denials uncontested? The reasons are practical, not irrational:

• Staffing limitations: Many practices do not have dedicated denial management staff. The same people who handle scheduling, check-in, billing, and patient communication are expected to manage denials as well. When denial volume exceeds available staff time, appeals are the first thing to be deprioritized.
• Lack of process: Without a structured workflow for identifying, triaging, and appealing denials, each appeal becomes a one-off project. Staff may not know where to find the denial reason, how to gather supporting documentation, or how to submit the appeal through the correct channel.
• Perceived low ROI: Many practices assume that appeals rarely succeed, so the effort is not worth the investment. This perception is not supported by the data, but it persists because practices that do not systematically track appeal outcomes have no evidence to the contrary.
• Missed deadlines: Every payer has appeal filing deadlines, and many are shorter than practices realize. By the time a denial is identified and triaged, the window for appeal may have already closed or be dangerously narrow.
• Complexity of clinical denials: Medical necessity denials require clinical evidence, guideline citations, and sometimes peer-to-peer review. For practices without clinical staff trained in appeal writing, these denials feel insurmountable.

The Compounding Effect

The cost of uncontested denials compounds over time in ways that go beyond the immediate revenue loss. When a practice consistently fails to appeal denials from a particular payer, it sends an implicit signal that the practice will accept adverse determinations without challenge. While there is limited evidence that payers explicitly track practice-level appeal rates, the absence of pushback removes any friction from the payer's denial decision-making.

Additionally, uncontested denials represent missed data. Every appeal — whether successful or not — generates information about payer behavior, denial patterns, and documentation requirements. Practices that do not appeal are flying blind, unable to identify the root causes of their denials or target prevention efforts effectively.

Closing the Gap

The gap between denials received and denials appealed is the single largest revenue recovery opportunity available to most physician practices. Closing that gap does not require appealing every denial — some truly are not worth the effort. But it does require a systematic approach to denial identification, triage, and appeal that ensures high-value denials are not silently written off.

The practices that recover the most revenue from denials are not necessarily the ones with the lowest denial rates. They are the ones that contest denials consistently, track their outcomes, and use the resulting data to improve both their appeal strategies and their upstream prevention efforts. The revenue is there. The question is whether your practice is collecting it.